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Abstract:  Mitochondrial quantity and density are associated with increased 17 
oxidative metabolism. It has been demonstrated that a hypocaloric high fat/low 18 
carbohydrate (HF/LC) diet can up-regulate transcriptional markers of mitochondrial 19 
biogenesis; this was yet to be explored in vivo subsequent to a high protein/low 20 
carbohydrate (HP/LC) diet. Thus the aims of the study were to explore such diets on 21 
transcriptional markers or mitochondrial biogenesis, body composition and resting 22 
metabolic rate (RMR). Forty-five healthy male participants were randomly assigned 23 
one of four intervention diets: eucaloric high protein (PRO-EM), hypocaloric high 24 
protein (PRO-ER), eucaloric high carbohydrate (CHO-EM) or hypocaloric high 25 
carbohydrate (CHO-ER). The macronutrient ratio of the high protein diet and high 26 
carbohydrate diets was 40:30:30% and 10:60:30 % (PRO:CHO:FAT) respectively. 27 
Energy intake for the hypocaloric diets were calculated to match resting metabolic 28 
rate. Participants visited the laboratory on 3 occasions each separated by 7 days. On 29 
each visit body composition, resting metabolic rate and a muscle biopsy from the 30 
vastus lateralis was collected. Prior to visit 1 and 2 habitual diet was consumed 31 
which was used as a control, between visit 2 and 3 the intervention diet was 32 
consumed continuously for 7-days. In the PRO-ER group a significant increase in 33 
AMPK, PGC-1α, SIRT1 and SIRT3 mRNA expression was observed, the increase in 34 
AMPK, PGC-1α was also than the other groups (p < 0.05). No change was observed 35 
in any of the transcriptional markers in the other 3 groups. Despite ~30 % reduction 36 
in calorie intake no difference in lean mass (LM) loss was observed between the 37 
PRO-ER and CHO-EM groups. The results from this study demonstrated that a 7-38 
day a high protein hypocaloric diet resulted in increased AMPK, SIRT1 and PGC-1 α  39 
mRNA expression at rest, also in a hypocaloric state increased dietary protein 40 
attenuated LM mass loss. 41 
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 42 
Keywords: High protein diet, PGC-1α, AMPK, hypocaloric, low carbohydrate diet  43 
 44 
Introduction 45 
 46 
Mitochondria are responsible for energy production via fatty-acid oxidation, Krebs 47 
cycle and oxidative phosphorylation. Mitochondria quantity and density has been 48 
linked with increased endurance performance [1], reduction in type 2 diabetes and 49 
improved insulin sensitivity [2-6]. A seminal paper from Puigserver, Wu [7] first 50 
described peroxisome proliferator-activated receptor gamma coactivator 1-alpha 51 
(PGC1-α), in the subsequent years PGC-1α had been identified as key for the 52 
regulation and co-activation of mitochondrial biogenesis [8]. 53 
 54 
Both AMP-activated protein kinase (AMPK) and silent information regulator T1 55 
(SIRT1) mediated deacetylation [9] have been demonstrated to regulate expression 56 
of PGC-1α in human muscle [10]. A substantial body of evidence suggests that 57 
SIRT1 expression responds to decreases in nutrient availability [11] and increases in 58 
energy expenditure [12]. Similarly AMPK is stimulated by cellular stressors that 59 
causes a depletion of adenosine triphosphate (ATP) and elevation of AMP, such as 60 
calorie restriction [13], hypoglycaemia [13] and exercise [14]. Subsequently, 61 
increases in PGC-1α mRNA expression can be observed in direct response to such 62 
stressors [13].  Acute hypocaloric HF/LC diets (50% fat, 30% carbohydrate and 20%, 63 
protein) significantly increases AMPK phosphorylation and PGC-1α deacetylation, 64 
this is not observed subsequent a hypocaloric low fat high carbohydrate (LF/HC) diet 65 
(20:60:20 %) [15], suggesting increased dietary carbohydrate intake prevents the 66 
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activation of the AMPK/SIRT – PGC-1α axis in skeletal muscle that would otherwise 67 
be activated by a low calorie diet. 68 
 69 
The preservation of lean mass is important for the maintenance of quality of life [16], 70 
it is generally accepted that weight loss strategies which preserve LM are 71 
preferential to those that results in skeletal muscle atrophy [17]. During hypocaloric 72 
diet-induced weight loss approximately 20 – 30% of mass lost is lean mass (LM) 73 
[18], increasing dietary protein is one method which has been demonstrated to 74 
attenuate skeletal muscle atrophy in a hypocaloric state [19]. The manipulation of 75 
carbohydrate intake as a regulator of weight maintenance / loss is well documented 76 
demonstrating improved lipid profile and fat oxidation [20, 21]. However, the majority 77 
of literature manipulates dietary fat – protein remains constant. A small number of 78 
metabolic perturbation murine studies have manipulated protein intake and it has 79 
been shown that high protein intake (35 % protein) increases PGC-1α expression 80 
relative to a control diet (15% protein) [22].  81 
 82 
In this field most research focuses on increasing dietary fat to restrict carbohydrate 83 
intake. However it is well documented the increased protein intake can attenuate LM 84 
loss and may be a preferable choice during weight loss. The impact high protein 85 
diets have on transcriptional markers of mitochondrial biogenesis is not fully 86 
explored. This study was designed to investigate the impact of increasing protein 87 
independently or alongside calorie restriction on metabolic adaptation, body 88 
composition and RMR.  89 
 90 
Materials and Methods 91 
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Participants 93 
 94 
Forty-eight healthy males volunteered to participate in the study with forty-five 95 
completing (mean ± SD: age 26.0 ± 5.1 years; body mass 74.9 ± 10.2 kg; height 96 
179.5 ± 5.9 cm). One participant was removed due to non-dietary adherence and 97 
two did not complete the study. Participants were initially screened against pre-98 
determined criteria to ensure they met the inclusion criteria and were free from any 99 
medical condition that would preclude participation in the study. Participants could 100 
not be following a restrictive dietary regime (vegetarian, vegan) or suffer from any 101 
food allergies/intolerances. Participants could not be participating in physical activity 102 
> 2 times per week and could not be consuming or have consumed any dietary or 103 
protein supplements in the previous 2 weeks. The experimental procedures and 104 
potential risks associated with the study were explained and the participants gave 105 
written informed consent prior to participation. None of the participants had a history 106 
of any neurological disease or musculoskeletal abnormality. The study was approved 107 
by the University of Hertfordshire School of Life and Medical Sciences ethics 108 
committee LMS/PG/UH/00196. 109 
 110 
Study Protocol 111 
 112 
In a randomised repeated-measures study design, the participants were assigned to 113 
one of four groups: energy matched high protein (PRO-EM, n = 11), energy 114 
restricted high protein (PRO-ER, n = 12), energy matched high carbohydrate (CHO-115 
EM, n = 12) or energy restricted high carbohydrate (CHO-ER, n = 10) (Table 1). The 116 
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participants attended the laboratory on three occasions, each separated by 7 days. 117 
Before visit 1 (baseline) and visit 2 (pre) all participants remained on their habitual 118 
diet, between visits 2 and visit 3 (post) the participants consumed the randomly 119 
assigned intervention diet. All experimental procedures were completed in the same 120 
order at the same time of the day. The baseline and pre assessments were used as 121 
a control to demonstrate stability of the measures assessed, where no differenced 122 
were observed between these measures the pre measures were used for analysis. 123 
 124 
Table 1 Prescribed macronutrient breakdown for each group. 125 
 Prescribed calorific intake Carbohydrate 
(%) 
Protein 
(%) 
Fat 
(%) 
PRO-EM 
Matched to estimated daily energy 
requirements 
30 40 30 
PRO-ER Restricted to resting metabolic rate 30 40 30 
CHO-EM 
Matched to estimated daily energy 
requirements 
60 10 30 
CHO-ER Restricted to resting metabolic rate 60 10 30 
(% = percentage of total daily calorific intake) 126 
 127 
Experimental protocol. 128 
 129 
Following an overnight fast the participants arrived at their allocated timeslot (start 130 
time range: 07:30 – 09:30 am) each testing visit. The participants were requested to 131 
arrive at the laboratory using the same mode of transport. Morning physical activity 132 
was not permitted. Prior to the pre and baseline visits the participants were 133 
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completed a standardised 4 day food dairy. The food diary was visually assessed for 134 
accuracy by the investigator and further detail was requested if required. An 135 
assessment of body composition (DXA scan) was then undertaken, followed by the 136 
measurement of resting metabolic rate. Finally a micro-muscle biopsy was collected 137 
(Figure 1).  138 
 139 
 140 
Figure 1. Schematic of experimental protocol.  141 
 142 
Measurement of habitual dietary intake 143 
 144 
A 4 day food diary using estimated household measures was used to collect habitual 145 
dietary intake prior to the pre and baseline visits. In the study briefing the participants 146 
were provided with a comprehensive example of the food diary and were instructed 147 
on how to complete it. The importance of accuracy and detail were emphasised, as 148 
was the importance of maintaining current dietary habits and documenting all food 149 
and drink consumed. Participants were requested to record intake on 3 week days 150 
and 1 weekend day each week, a total of 8 days dietary intake was collected over 151 
the 2 week prior visit 1 and visit 2.  152 
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 153 
Body composition assessment: Dual energy x-ray absorptiometry (DXA) scan 154 
 155 
All metal and piercings were removed and fasted body mass (BM) was measured 156 
using a digital column scale (seca 704, seca Ltd., Hamburg, Germany). A full body 157 
DXA scan (GE Lunar iDXA, GE Healthcare, UK) was performed in accordance with 158 
the manufacturer’s guidelines for patient positioning and was analysed using 159 
enCORE Software, version 14.10 (GE Healthcare, Bucks, UK). The scan measured 160 
BM, total LM and total fat mass (FM). All scans were performed by a fully trained 161 
operator. In addition to regular machine calibration, a standard quality assurance 162 
procedure was performed each testing day.  163 
 164 
Resting metabolic rate (RMR) 165 
 166 
RMR was measured using indirect calorimetry (coefficient of variation = 1.48 %). All 167 
assessments were completed in a temperature controlled environmental chamber 168 
(temperature set to 24oC). The participants arrived at the laboratory in the morning 169 
following an overnight fast. The participants were requested to expel as little energy 170 
as possible prior to arrival. The participant lay in a supine position on a couch and a 171 
large towel was placed over their body to maintain comfort. Once comfortable a 172 
metabolic hood (Gas Exchange Measurement (GEM), GEMNutrition Ltd, UK) was 173 
placed over the participants head. The participant was instructed to relax, breathe 174 
normally and not to move or fall asleep. The GEM was set to collect respiratory bins 175 
every 60 seconds for 20 minutes, the data analysed was from the final 5 minutes of 176 
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colleciton. Throughout the test the participant was observed through a window to 177 
check for adherence. RMR was calculated using the modified Weir equation [23]: 178 
 179 
“RMR = 1.44 x (3.9 x V̇O2 + 1.1 x V̇CO2)” 180 
 181 
Respiratory exchange ratio was calculated to assess for changes in resting substrate 182 
utilisation by dividing the V̇CO2 value (L•min-1) by the V̇O2 value (L•min-1) from each 183 
minute bin collected on the GEM.  184 
 185 
Micro muscle biopsy 186 
 187 
Muscle biopsies were obtained from the midpoint on the lateral aspect of the right 188 
vastus lateralis muscle. The biopsy site was cleaned using Betadine (Pardue 189 
Products, USA) and samples were obtained under local anaesthesia, 2 ml of 1 % v/v 190 
without adrenaline Lidocaine Hydrochloride (Hameln Pharmaceuticals: cat. no 191 
PL01502) was injected into the subcutaneous fat of the selected biopsy site. Once 192 
the anaesthetic had taken effect (~5 minutes), a 14 gauge co-axial was inserted ~2 193 
cm into the muscle, a disposable core biopsy instrument (TSK Stericut Biopsy 194 
Needle 14 Gauge, TSK Laboratories, Japan) was then inserted through the co-axial 195 
and activated. A single biopsy pass was used collecting approximately 10 - 20 mg of 196 
muscle tissue. The biopsy instrument was immediately removed from the leg and 197 
within 10 seconds the muscle tissue was removed from the biopsy instrument using 198 
a sterile scalpel and flash frozen in liquid nitrogen. The muscle sample was placed in 199 
an RNAse free plastic vial and stored at -80 OC under the HTA license number 200 
12202 until analysis. 201 
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Dietary prescription 203 
 204 
For the two energy restricted (ER) groups the participants were provided an 205 
intervention diet with an energy intake that met RMR. RMR was calculated from the 206 
GEM result attained from Visit 1. For the energy matched (EM) groups, energy 207 
intake was calculated according the World Health Organisation [24] lifestyle 208 
dependent physical activity multiplier:  209 
 210 
“EI = PAF x RMR” 211 
EI = Energy intake, PAF = physical activity factor, RMR = resting metabolic rate 212 
 213 
RMR was attained from the GEM result on visit 1, and PAF was selected following a 214 
series of lifestyle questions concerning daily activity levels, type of work and exercise 215 
activity (Table 2). 216 
 217 
Table 2. Lifestyle dependent physical activity multiplier used to calculate energy 218 
intake [24]. 219 
Activity level Calculation 
Low 1.53 x RMR 
Moderate 1.77 x RMR 
Active 2.25 x RMR 
 220 
A total of 34 (17 high carbohydrate, 17 high protein) different diet menus were 221 
created starting at 1,075 kcal, increasing by 150 kcal for each different diet up to 222 
3,325 kcal. Participants were assigned the diet closest to their calculated 223 
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interventional energy intake. The greatest difference between estimated intervention 224 
diet and prescribed diet was 75 kcal per day. 225 
 226 
All intervention meals were created by Soulmatefood® (Waterfoot, Lancashire, UK) 227 
and directly delivered to the participant’s door (Table 3). Each participant received 228 
two deliveries; the first delivery contained three day’s food, the second four day’s 229 
food. Each day consisted of 5 pre packaged/cooked meals (breakfast, morning 230 
snack, lunch, afternoon snack and dinner). Included with the delivery was a daily 231 
menu with consumption instructions. The participants were required to refrain from 232 
consuming any additional food and just drink water or fluids free from caffeine or 233 
energy. 234 
 235 
Table 3. Prescribed daily calorie intake and macronutrient breakdown for each group 236 
throughout the 7-day intervention.  237 
Group 
Dietary 
intake 
(kcal•day-1) 
CHO (•day-1) PRO (•day-1) FAT (•day-1) 
g g•kg-1 g g•kg-1 g g•kg-1 
PRO-EM 2828 ± 331 217 ± 26 3.0 ± 0.5 289 ± 34 4.0 ± 0.7 96 ± 11 1.3 ± 0.2 
PRO-ER 1876 ± 116 143 ± 9 1.9 ± 0.3 191 ± 12 2.5 ± 0.4 64 ± 4 0.8 ± 0.1 
CHO-EM 2881 ± 213 444 ± 33 6.1 ± 0.6 75 ± 6 1.0 ± 0.1 97 ± 7 1.3 ± 0.1 
CHO-ER 1735 ± 246 267 ± 37 3.7 ± 0.7 45 ± 6 0.6 ± 0.1 59 ± 8 0.8 ± 0.2 
  238 
 239 
Quantitative PCR (qPCR) 240 
 241 
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RNA Isolation: Human muscle biopsies were homogenised in 700 µL MagNA Pure 242 
LC RNA Isolation Tissue Lysis buffer (Roche, Mannheim, Germany) in Roche 243 
MagNA Lyser Green bead tubes at 6500 rpm for 30 seconds. After homogenisation, 244 
the tubes were centrifuged for 10 min at 13,000g before 350 µL of each homogenate 245 
was used for RNA extraction. Total RNA was extracted using the MagNA Pure 96 246 
Cellular RNA Large Volume Kit on a MagNA Pure 96 (Roche, Mannheim, Germany), 247 
in an elution volume of 50 µL according to the manufacturer's protocol. RNA was 248 
stored at -80 OC. RNA concentrations were determined (A260) using a NanoQuant 249 
plate on a Tecan Infinite 200PRO. RNA quality (RNA integrity number equivalent, 250 
RINe) was assessed using RNA ScreenTape on a 2200 TapeStation (Agilent, Santa 251 
Clara, USA). 252 
 253 
Reverse Transcription: As a result of the large sample number and the automated 254 
process, RNA concentration was not taken into account for each individual reaction. 255 
14 µL of each RNA sample was reverse transcribed in a total volume of 20 µL using 256 
the High capacity cDNA reverse transcription kit (without RNase inhibitor, Applied 257 
Biosystems, Thermo Fisher, Loughborough, UK). The average RNA concentration 258 
across the 142 samples was 32.4 ng•µL-1 equating to an average of 453ng 259 
RNA/reverse transcription reaction. Reactions were performed in 96 well PCR plates 260 
on a PTC-225 Peltier thermal cycler (MJ Research, Quebec, Canada) using the 261 
following profile; 25°C for 10 minutes, 37°C for 60  minutes, 85°C for 5 minutes, 4°C 262 
hold.  Minus RT control reactions were set up for 14 samples, in which the RNA 263 
component was replaced with nuclease free water (Ambion, Fisher Scientific, 264 
Loughborough, UK).  265 
 266 
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qPCR: For quantitative real-time PCR (qPCR), Human TaqMan® gene expression 267 
assays  were purchased as a 20X assay ready stock from Life Technologies 268 
(Carlsbad, USA) (primers 18 mM and probes 5 mM) (Table 4). 1 µL cDNA was 269 
added to each qPCR reaction mixture which also contained gene expression assay 270 
mix (primers 900 nM final, probe 250 nM final), LightCycler 480 Probes Master and 271 
nuclease free water to give a 5 µL total reaction volume. Reactions were prepared in 272 
white multiwell 384 plates (Roche, Mannheim, German) using a Mosquito HV (TTP 273 
Labtech, Melbourn, UK). The plates were sealed using optical seals (Roche, 274 
Mannheim, Germany) and centrifuged at 290g for 2 min before being run on a 275 
LightCycler® 480 instrument (Roche, Mannheim, Germany) with the following 276 
thermal cycling parameters: initial de-naturation step 95°C for 10 min, followed by 45 277 
cycles of denaturation at 95°C for 10 s and primer annealing/extension at 60°C for 278 
30 s. A cooling step at 40°C for 30 s was the final  stage of the run. 279 
 280 
Table 4. Taqman Assays on Demand information (Applied Biosystems) 281 
Gene name Gene 
abbreviation 
Assay on 
Demand 
number 
Silent information regulator-T1 (SIRT1) SIRT1 Hs01009005_m1 
Silent information regulator-T3 (SIRT3) SIRT3 Hs00953477_m1 
AMP-activated protein kinase 1 (AMPK) PRKAA1 Hs01562315_m1 
Peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha (PGC-1α) 
 
PPARGC1 
 
Hs01016719_m1 
Peroxisome proliferator-activated receptor 
delta (PPARδ) 
PPARδ Hs00987011_m1 
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Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) 
GAPDH Hs99999905_m1 
 282 
The crossing point (Cp) value for each sample was calculated using the second 283 
derivative maximum method applied directly by the Roche software to the real-time 284 
amplification curves. This value represents the cycle at which the increase of 285 
fluorescence is highest and where the logarithmic phase of a PCR begins. 286 
 287 
Amplification Efficiency of qPCR assays: The efficiency of each of the Taqman® 288 
assays on demand was confirmed by performing standard curves in a 384 well 289 
qPCR assay on the LightCycler® 480 under the same conditions as already 290 
described. Six point standard curves with 1 in 10 serial dilutions were prepared in 291 
nuclease free water for human plasmid DNA for each of the genes being tested 292 
alongside Human genomic DNA with a top concentration of 3e5 copies/µL and 1e5 293 
copies/µL respectively. qPCR reactions were performed in triplicate and the 294 
amplification efficiency calculated for each Taqman® assay on the basis of the 295 
equation E = (10–1/slope –1) × 100 with the logarithm of the template concentration 296 
on the x axis and the average Cp plotted on the y axis. 297 
 298 
Statistical analysis 299 
 300 
The RMR and body composition data were analysed using a 2-way repeated 301 
measures ANOVA with dietary intake (between) and time point (within) as the main 302 
variables. Significant interaction effects were analysed with the use of LSD post hoc 303 
test to determine the location of the pairwise differences within (time) and/or between 304 
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(dietary intake). The muscle biopsy qPCR analysis raw Cp values were normalised 305 
to the house keeper gene (GAPDH) using an analysis of covariance method, before 306 
relative fold change over baseline (visit 1) were calculated using 2-∆∆CT. Visit one and 307 
visit two were used as control. Statistical analysis of the qPCR fold change data was 308 
assessed using a paired sample t-test to determine the difference between the 309 
control trials, where no difference was observed a paired sample test was run to 310 
assess pre-post intervention relative fold change (time) difference. Pre – post 311 
intervention group difference was assessed using a one way ANOVA. Statistical 312 
significance was set at p < 0.05. Statistical analysis was conducted using the 313 
statistical package for the Social Science software program (SPSS; version 22, IBM, 314 
Armonk, NY). All data are presented mean ± SEM unless specified.  315 
  316 
Results 317 
 318 
Habitual dietary intake 319 
No time or group interactions were observed for habitual total calorie intake or 320 
macronutrient breakdown (Table 5). The mean daily calorific intake across all groups 321 
was 2,340 ± 473 kcal•day-1 (range 2,192 ± 574 to 2423 ± 330 kcal•day-1).  322 
 323 
Table 5. Average daily habitual calorific intake and macronutrient breakdown for 324 
each group prior to intervention diet. (mean ± SD and percentage (%) of total energy 325 
intake). 326 
 
Mean daily 
calorie intake 
CHO PRO FAT 
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(kcal•day-1) g•day-1 % g•day-1 % g•day-1 % 
PRO-EM 2192 ± 173 232 ± 22 42.4 95 ± 6 17.2 86 ± 6 35.2 
PRO-ER 2391 ± 133 267 ± 16 44.7 100 ± 8 16.7 93 ± 5 35.0 
CHO-EM 2355 ± 152 274 ± 23 46.6 103 ± 9 17.5 89 ± 8 33.8 
CHO-ER 2407 ± 107 307 ± 16 51.7 97 ± 7 16.0 84 ± 5 31.4 
A total of 8 days dietary intake was collected over the 2 week prior visit 1 and visit 2; 327 
participants were requested to record intake on 3 week days and 1 weekend day 328 
each week using the estimated household measures method. (CHO = carbohydrate, 329 
PRO = protein, FAT = fat). % = percentage of dietary intake 330 
 331 
 332 
Gene expression 333 
 334 
No significant difference was observed between TP1 and TP2 in any of the genes, 335 
thus it can be assumed that any post intervention changes observed were due to the 336 
intervention rather than the internal variability of the measure.  337 
 338 
 No significant group interactions were observed in any of the genes, however it is 339 
important to note trends towards group interactions were observed within both PGC-340 
1α (f = 2.654, p = 0.063) and AMPK (f = 2.771, p = 0.056) expression. Within the 341 
PRO-ER group significant pre-post intervention time point difference was observed 342 
in PGC-1α (fold increase = 1.27, p = 0.0402), AMPK (fold increase = 2.09, p = 343 
0.027), SIRT1 (fold increase = 1.50, p = 0.026) and SIRT3 (fold increase = 1.19, p = 344 
0.010) mRNA expression). No time point gene expression changes were observed in 345 
any other dietary group (Figure 2 A-E), or in the expression of PPAR mRNA.   346 
 347 
A significant change in LM was observed post intervention as were significant group 348 
difference. Post intervention 3 or the groups lost LM (p < 0.05) (Figure 3A), the CHO-349 
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ER losing the greatest amount (-1.26 ± 0.14 kg), the PRO-ER losing -0.82 ± 0.3 kg 350 
and CHO-EM losing -0.53 ± 0.19 kg respectively. LM was maintained in the PRO-EM 351 
group (-0.21 ± 0.17 kg). The CHO-ER group lost significantly more LM than both the 352 
PRO-EM and CHO-EM groups (p < 0.05), no difference in LM was observed 353 
between the PRO-ER and CHO-EM groups. 354 
 355 
The PRO-ER and CHO-ER groups lost greater (p < 0.05) BM than both CHO-EM 356 
and PRO-EM (Figure 3B). No difference was observed between groups matched for 357 
energy intake. All groups exhibited a significant loss in FM (p < 0.01) post 7-days 358 
dietary intervention (Figure 1B). The PRO-ER lost the greatest amount of FM (-0.99 359 
± 0.11 kg) and the CHO-EM group lost the least (-0.50 ± 0.14 kg). The difference 360 
between these two groups was the only significant group difference observed (p < 361 
0.05),  362 
 363 
 364 
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 365 
A      B 
 
C      D 
  
E 
 
Figure 2. Effect of feeding 7-days diet intervention on mRNA expression at rest. 
Effect of 7-days high protein energy matched (PRO-EM), high protein energy 
restricted (PRO-ER), high carbohydrate energy matched (CHO-EM) or high 
carbohydrate energy restricted (CHO-ER) diet in healthy lean individuals on 
PCG-1α (A), AMPK (B), SIRT1 (C), SIRT3 (D) and PPAR (E) mRNA 
expression. Muscle samples were obtained following an overnight fast prior to 
the intervention and repeated again following 7-days dietary intervention (Post). 
Values are expressed as fold change (pre to post) after normalization to the 
reference gene (GAPDH) and are reported as the mean ± SE. For abbreviations 
of genes see Table 4. *p < 0.05 versus Pre intervention. 
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 366 
 367 
A reduction in BM was observed post intervention in all groups (p < 0.01, Figure 3C). 368 
The PRO-EM group lost the least BM (-0.74 ± 0.24 kg) whereas the CHO-ER lost the 369 
greatest (-2.21 ± 0.17 kg). Significant post intervention group differences were 370 
observed (p < 0.01), this was not seen in grouped matched for energy intake, 371 
however both ER groups lost significantly more BM than EM groups. 372 
A          B 
 
C  
 
Figure 3. Effect of either 7-days continuous high protein energy matched (PRO-
EM), high protein energy restricted (PRO-ER), high carbohydrate energy 
matched (CHO-EM) or high carbohydrate energy restricted (CHO-ER) diet on 
lean mass (kg) (A), fat mass (kg) (B) and body mass (kg) (C) at rest in lean 
healthy individuals. The data presented as mean ± SEM; * denotes significant 
difference between PRO-EM and PRO-ER, ** denotes significant difference 
between CHO-EM and CHO-ER, # denotes significant difference between PRO-
EM and CHO-ER and ## denotes significant difference between PRO-ER and 
CHO-EM. (p < 0.05). 
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 373 
No time or group interaction effects were observed in RMR (Table 6). Mean RMR 374 
across all groups pre was 1910 ± 180 kcal vs. 1894 ± 184 post intervention.  375 
 376 
Table 6. Resting metabolic rate (RMR) (kcal•day-1) pre and post 7-day dietary 377 
intervention (Mean ± SEM). 378 
  
RMR PRE 
(kcal•day-1) 
RMR POST 
(kcal•day-1) 
PRO-EM 1916 ± 73 1910 ± 70 
PRO-ER 1904 ± 37 1950 ± 54 
CHO-EM 1972 ± 38 1946 ± 44 
CHO-ER 1848 ± 69 1768 ± 52 
 379 
      380 
 381 
Discussion 382 
       383 
This is the first acute dietary intervention study in healthy sedentary males to 384 
demonstrate that increased dietary protein intake in a hypocaloric state positively 385 
increased mRNA expression of PGC-1α and AMPK.  386 
 387 
In a myoblast cell line it has previously been demonstrated that both calorie and 388 
carbohydrate restriction independently increase transcriptional markers of 389 
mitochondrial biogenesis. Following 36- hours incubation in a low glucose solution (5 390 
mM) a > 2.5 fold increase in PGC-1α transcriptional activity was observed relative to 391 
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a high glucose solution (25 mM), additionally the same authors also demonstrated 392 
that following a 20-hour fast, relative PGC-1α mRNA levels were increased > 2 fold, 393 
suggesting positive activity in vitro of energy and glucose restriction independently 394 
[25]. However, in vivo results from the current study demonstrated no change in 395 
mRNA expression in the PRO-EM (carbohydrate restriction) or CHO-ER (energy 396 
restriction) groups, suggesting that acute carbohydrate restriction and energy 397 
restriction independently do not exert sufficient metabolic stress to elicit metabolic 398 
changes at an mRNA level. Furthermore the results from this study showed that 399 
subsequent to a continuous, hypocaloric, high protein diet (40% protein (~ 2.5 g•kg-400 
1
•day1) and ~33 % energy deficit) a small, but significant, increase in resting mRNA 401 
expression of AMPK, SIRT1, SIRT3 and PGC-1α in the vastus lateralis muscle was 402 
observed. Furthermore, although non-significant, a tread towards a group interaction 403 
of AMPK (p = 0.056) and PGC-1α (p = 0.063) gene expression was observed. Due 404 
to two lost samples in the CHO-ER group at TP3 this resulted in unbalanced groups. 405 
When statistics were re-run with phantom values for these two missing points the 406 
groups interactions were apparent with the POR-ER group eliciting a significantly 407 
greater response in post intervention gene expression relative to all other groups. 408 
This would also suggest that the study may have been slightly under powered. 409 
These results imply that, in contrast to independent restriction, the combination of 410 
energy and carbohydrate restriction provides sufficient metabolic stress to cause 411 
skeletal muscle adaptation to cope with the energy demands.  412 
 413 
These results are corroborated by similar studies investigating the impact of high fat 414 
feedings on mitochondrial biogenesis [15, 25]. It was shown that five days on a 415 
hypocaloric HF/LC diet positively increased phosphorylation of AMPK and 416 
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deacetylation of PGC-1α, where as the hypocaloric LF/HC diet negatively reduced 417 
the phosphorylation of AMPK and deacetylation of PGC-1α [15]. These results, along 418 
with the findings from the current study suggest that high carbohydrate intake 419 
prevents the activation of the AMPK-SIRT1 axis that is otherwise observed in a 420 
hypocaloric state. Furthermore, and importantly the method of carbohydrate 421 
restriction does not seem important, increasing both dietary fat and/or protein result 422 
in similar up-regulation of metabolic markers of mitochondrial biogenesis. 423 
        424 
It is considered that weight loss strategies that result in maintenance of LM and 425 
promote greater FM loss are preferential [4]. It has previously been demonstrated 426 
that ~70 % of weight lost, induced by a hypocaloric diet, is attributed to FM and 30 % 427 
from LM [26]. Furthermore it has been reported in obese women that increased 428 
protein intake (1.6 g•kg-1•day-1 vs. 0.8 g•kg-1•day-1) increased FM loss and improved 429 
maintenance of lean mass [27]. The results from this study corroborate this in a 430 
healthy male population. No between group difference was observed in energy-431 
matched conditions for BM, FM or LM. The CHO-ER group lost significantly more LM 432 
than the CHO-EM group, interestingly however no difference in LM loss was 433 
observed between the PRO-ER and CHO-EM groups. The PRO-EM group had a 434 
higher protein intake relative to the CHO-EM group (2.5 g•kg-1•day-1 vs. 1.0 g•kg-435 
1
•day-1). Thus, although the calorie intake of the PRO-ER group was ~33 % less than 436 
that of the CHO-EM group (total deficit of ~7,000 kcal over the 7-day intervention) no 437 
change in LM was observed between groups, further highlighting the key role for 438 
protein in LM maintenance. The mechanism of this is still not fully defined. The 439 
dietary protein intake of the CHO-EM group was greater than the current reference 440 
nutrient intake in the UK for adults of 0.75 g•kg-1•day-1
 
[28], however it has been 441 
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demonstrated the proteolysis of skeletal muscle is suppressed when consuming ≥ 442 
1.5 g•kg-1•day-1 of protein [29]. The PRO-ER group consumed 2.5 g•kg-1•day-1 of 443 
protein, significantly above this threshold. 444 
 445 
With regards to weight loss ratios, the results demonstrate that in a hypocaloric diet 446 
dietary protein intake can positively impact LM and FM loss. Following a continuous 447 
hypocaloric diet (~33% energy deficit) and independent of macronutrient content 448 
both groups lost a significant amount of LM. Approximately 44% of total BM loss in 449 
the PRO-ER group was attributed to LM loss compared to 56% in the CHO-ER 450 
group. This was coupled with a greater percentage of FM loss in the PRO-ER group 451 
(56% vs. 44% respectively). As such, increased dietary protein intake (2.5 g•kg-1 vs. 452 
0.6 g•kg-1) attenuated LM loss by ~12 % relative to a hypocaloric diet low in protein. 453 
A recent meta-analysis [30] investigating the role of dietary protein intake and long 454 
term body composition changes (12 ± 9 weeks) concluded higher protein diets led to 455 
greater BM loss (-0.79 kg), FM loss (-0.87 kg) and preserved more LM (+0.43 kg) 456 
relative to lower protein diets. Although over a shorter period, the body composition 457 
results from the hypocaloric groups observed in this study followed the same trends 458 
with -0.35 kg BM, -0.09 kg FM and +0.44 kg LM body composition changes 459 
observed. It has been demonstrated that a positive curvilinear (r2 = 0.92) relationship 460 
exists between LM and RMR [31], and RMR is known to decline during prolonged (> 461 
9 months) periods of energy restriction [32]. The thermic effect of macronutrients 462 
should also be considered, protein has a greater thermic effect compared with the 463 
equivalent energy intake of fat or carbohydrate [33]. However the acute nature of the 464 
intervention was not long enough the elicit change in RMR and no time point 465 
difference or group interaction was observed in RMR, thus it may be assumed that 466 
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the duration of the study was not long enough to elicit changes in RMR, as such 467 
metabolic rate is not impacted by such a short dietary intervention.  468 
 469 
A marked reduction in RER post intervention was observed in both ER groups; 470 
however caution should be taken when drawing strong conclusions from this data. 471 
Pre intervention both ER groups had a higher RER (PRO-ER = 0.89, CHO-ER = 472 
0.85, PRO-EM = 0.83, CHO-EM = 0.83) and post intervention all groups had an RER 473 
of 0.79. Thus a greater relative change was observed pre-post intervention in the ER 474 
groups, but no group interaction was apparent. In mice and subsequent to 8 weeks 475 
on a hypocaloric diet a significant reduction in RER was observed compared to 476 
relative to energy matched diets [34]. Similar to the results from this study, RER was 477 
reduced to the same level in the hypocaloric group’s independent of dietary protein 478 
intake (5% vs. 33% vs. 60%). Solon-Biet, Mitchell [34] also reported a significant 479 
reduction in RER in the eucaloric high protein group relative to the eucaloric high 480 
protein diet, however this was not to the amplitude of the any of the hypocaloric 481 
diets. This suggests that in an eucaloric state restricted carbohydrate (increased 482 
protein intake) results in a reduction in RER, however calorie restriction has a 483 
greater metabolic impact, independent on macronutrient ratio.  484 
 485 
Interestingly this study raises further considerations for dietary prescription studies 486 
and methods used to measure energy intake. The mean calorie intake calculated 487 
from 2 x 4 day food diaries for each participant in the PRO-EM and CHO-EM groups 488 
were 2,192 ± 574 kcal•day-1 and 2,355 ± 527 kcal•day-1, respectively. However, 489 
mean calculated energy intake from RMR X Activity Factor (AF) were 2,828 ± 331 490 
kcal•day-1 and 2,881 ± 213 kcal•day-1, a difference of 636 and 526 kcal•day-1, 491 
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respectively. Despite meticulous effort to match the dietary intake of the PRO-EM 492 
and CHO-EM to energy expenditure the results demonstrated a small reduction in 493 
BM in both group (0.74 kg and 1.1 kg respectively), as such dietary prescription was 494 
slightly underestimated. Despite this, habitual diet, as recorded using estimated 495 
household measures, under predicted energy intake calculated using RMR x PA by 496 
~20%, a similar percentage to previous findings in athletes [35] (~28 %) and 497 
sedentary participants [36] (~20%).   498 
 499 
1.1 Conclusions 500 
 501 
Mitochondrial quantity and density have been linked with increased endurance 502 
performance [1] and a reduction in type 2 diabetes [2-6]. Also, it is suggested that 503 
dietary strategies that maintain LM are preferential. This is the first study to 504 
demonstrate the impact of increased protein intake in a hypocaloric diet on metabolic 505 
adaptation. The results from this study demonstrated that a 7-day a high protein 506 
hypocaloric diet resulted in increased AMPK, SIRT1, SIRT3 and PGC-1α mRNA 507 
expression at rest, all of which are upstream markers of mitochondrial biogenesis. 508 
Additionally increased protein intake helped to maintain LM mass in a hypocaloric 509 
state. Thus, it may be concluded that a high protein, hypocaloric diet is preferential to 510 
a high carbohydrate, hypocaloric diet with respect to cellular markers of fat 511 
metabolism and also the maintenance of lean mass. However future research is 512 
needed to understand the long-term impact of a high protein hypocaloric diet on 513 
markers of mitochondrial biogenesis and body composition.  514 
 515 
References 516 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 517 
1. Psilander, N., et al., Exercise with low glycogen increases PGC-1alpha 518 
gene expression in human skeletal muscle. Eur J Appl Physiol, 2013. 519 
113(4): p. 951-63. 520 
2. Lee, H.K., et al., Decreased mitochondrial DNA content in peripheral 521 
blood precedes the development of non-insulin-dependent diabetes 522 
mellitus. Diabetes Res Clin Pract, 1998. 42(3): p. 161-7. 523 
3. De Feyter, H.M., et al., Increased intramyocellular lipid content but 524 
normal skeletal muscle mitochondrial oxidative capacity throughout the 525 
pathogenesis of type 2 diabetes. FASEB J, 2008. 22(11): p. 3947-55. 526 
4. Patti, M.E., et al., Coordinated reduction of genes of oxidative 527 
metabolism in humans with insulin resistance and diabetes: Potential 528 
role of PGC1 and NRF1. Proc Natl Acad Sci U S A, 2003. 100(14): p. 8466-529 
71. 530 
5. Petersen, K.F., et al., Impaired mitochondrial activity in the insulin-531 
resistant offspring of patients with type 2 diabetes. N Engl J Med, 2004. 532 
350(7): p. 664-71. 533 
6. Mootha, V.K., et al., PGC-1alpha-responsive genes involved in oxidative 534 
phosphorylation are coordinately downregulated in human diabetes. Nat 535 
Genet, 2003. 34(3): p. 267-73. 536 
7. Puigserver, P., et al., A cold-inducible coactivator of nuclear receptors 537 
linked to adaptive thermogenesis. Cell, 1998. 92(6): p. 829-39. 538 
8. Liang, H. and W.F. Ward, PGC-1alpha: a key regulator of energy 539 
metabolism. Adv Physiol Educ, 2006. 30(4): p. 145-51. 540 
9. Gurd, B.J., et al., The deacetylase enzyme SIRT1 is not associated with 541 
oxidative capacity in rat heart and skeletal muscle and its 542 
overexpression reduces mitochondrial biogenesis. J Physiol, 2009. 543 
587(Pt 8): p. 1817-28. 544 
10. Ruderman, N.B., et al., AMPK and SIRT1: a long-standing partnership? 545 
Am J Physiol Endocrinol Metab, 2010. 298(4): p. E751-60. 546 
11. Nemoto, S., M.M. Fergusson, and T. Finkel, SIRT1 functionally interacts 547 
with the metabolic regulator and transcriptional coactivator PGC-548 
1{alpha}. J Biol Chem, 2005. 280(16): p. 16456-60. 549 
12. Suwa, M., et al., Endurance exercise increases the SIRT1 and 550 
peroxisome proliferator-activated receptor gamma coactivator-1alpha 551 
protein expressions in rat skeletal muscle. Metabolism, 2008. 57(7): p. 552 
986-98. 553 
13. Itani, S.I., et al., Glucose autoregulates its uptake in skeletal muscle: 554 
involvement of AMP-activated protein kinase. Diabetes, 2003. 52(7): p. 555 
1635-40. 556 
14. Fujii, N., et al., Exercise induces isoform-specific increase in 5'AMP-557 
activated protein kinase activity in human skeletal muscle. Biochem 558 
Biophys Res Commun, 2000. 273(3): p. 1150-5. 559 
15. Draznin, B., et al., Effect of dietary macronutrient composition on AMPK 560 
and SIRT1 expression and activity in human skeletal muscle. Horm 561 
Metab Res, 2012. 44(9): p. 650-5. 562 
16. Janssen, I., S.B. Heymsfield, and R. Ross, Low relative skeletal muscle 563 
mass (sarcopenia) in older persons is associated with functional 564 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
impairment and physical disability. J Am Geriatr Soc, 2002. 50(5): p. 889-565 
96. 566 
17. Stiegler, P. and A. Cunliffe, The role of diet and exercise for the 567 
maintenance of fat-free mass and resting metabolic rate during weight 568 
loss. Sports Med, 2006. 36(3): p. 239-62. 569 
18. Areta, J.L., et al., Reduced resting skeletal muscle protein synthesis is 570 
rescued by resistance exercise and protein ingestion following short-571 
term energy deficit. Am J Physiol Endocrinol Metab, 2014. 306(8): p. 572 
E989-97. 573 
19. Stuart, C.A., et al., Effect of dietary protein on bed-rest-related changes 574 
in whole-body-protein synthesis. Am J Clin Nutr, 1990. 52(3): p. 509-14. 575 
20. Boden, G., et al., Effect of a low-carbohydrate diet on appetite, blood 576 
glucose levels, and insulin resistance in obese patients with type 2 577 
diabetes. Ann Intern Med, 2005. 142(6): p. 403-11. 578 
21. Hussain, T.A., et al., Effect of low-calorie versus low-carbohydrate 579 
ketogenic diet in type 2 diabetes. Nutrition, 2012. 28(10): p. 1016-21. 580 
22. Nakazato, K. and H. Song, Increased oxidative properties of 581 
gastrocnemius in rats fed on a high-protein diet. J Nutr Biochem, 2008. 582 
19(1): p. 26-32. 583 
23. Weir, J.B., New methods for calculating metabolic rate with special 584 
reference to protein metabolism. J Physiol, 1949. 109(1-2): p. 1-9. 585 
24. World-Health-Organization, Diet, nutrition, and the prevention of chronic 586 
diseases: report of a joint WHO/FAO expert consultation. Vol. 916. 2003: 587 
Diamond Pocket Books (P) Ltd. 588 
25. Canto, C., et al., Interdependence of AMPK and SIRT1 for metabolic 589 
adaptation to fasting and exercise in skeletal muscle. Cell Metab, 2010. 590 
11(3): p. 213-9. 591 
26. Weinheimer, E.M., L.P. Sands, and W.W. Campbell, A systematic review 592 
of the separate and combined effects of energy restriction and exercise 593 
on fat-free mass in middle-aged and older adults: implications for 594 
sarcopenic obesity. Nutr Rev, 2010. 68(7): p. 375-88. 595 
27. Layman, D.K., et al., A reduced ratio of dietary carbohydrate to protein 596 
improves body composition and blood lipid profiles during weight loss 597 
in adult women. J Nutr, 2003. 133(2): p. 411-7. 598 
28. Foundation, B.N., Nutrition Requirements, B.N. Foundation, Editor. 2015: 599 
nutrition.org.uk. 600 
29. Piatti, P.M., et al., Hypocaloric high-protein diet improves glucose 601 
oxidation and spares lean body mass: comparison to hypocaloric high-602 
carbohydrate diet. Metabolism, 1994. 43(12): p. 1481-7. 603 
30. Wycherley, T.P., et al., Effects of energy-restricted high-protein, low-fat 604 
compared with standard-protein, low-fat diets: a meta-analysis of 605 
randomized controlled trials. Am J Clin Nutr, 2012. 96(6): p. 1281-98. 606 
31. Weinsier, R.L., Y. Schutz, and D. Bracco, Reexamination of the 607 
relationship of resting metabolic rate to fat-free mass and to the 608 
metabolically active components of fat-free mass in humans. Am J Clin 609 
Nutr, 1992. 55(4): p. 790-4. 610 
32. Heshka, S., et al., Weight loss and change in resting metabolic rate. Am 611 
J Clin Nutr, 1990. 52(6): p. 981-6. 612 
33. Malik, V.S. and F.B. Hu, Popular weight-loss diets: from evidence to 613 
practice. Nat Clin Pract Cardiovasc Med, 2007. 4(1): p. 34-41. 614 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
34. Solon-Biet, S.M., et al., Dietary Protein to Carbohydrate Ratio and 615 
Caloric Restriction: Comparing Metabolic Outcomes in Mice. Cell Rep, 616 
2015. 11(10): p. 1529-34. 617 
35. Magkos, F. and M. Yannakoulia, Methodology of dietary assessment in 618 
athletes: concepts and pitfalls. Curr Opin Clin Nutr Metab Care, 2003. 619 
6(5): p. 539-49. 620 
36. Stockley, L., Changes in habitual food intake during weighed inventory 621 
surveys and duplication diet collections. A short review. Ecology of 622 
Food and Nutrition, 1985. 17(3): p. 263-269. 623 
 624 
